Epileptic	epileptic	O	DISEASE	OTHERS	I
seizures	seizures	O	DISEASE	OTHERS	I
following	following	O	O	O	O
cortical	cortical	O	O	O	O
application	application	O	O	O	O
of	of	O	O	O	O
fibrin	fibrin	O	O	O	O
sealants	sealants	O	O	O	O
containing	containing	O	O	O	O
tranexamic	tranexamic	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

BACKGROUND	background	O	O	O	O
:	:	O	O	O	O
Fibrin	fibrin	O	O	O	O
sealants	sealants	O	O	O	O
(	(	O	O	O	O
FS	fs	O	O	O	O
)	)	O	O	O	O
derived	derived	O	O	O	O
from	from	O	O	O	O
human	human	O	O	O	O
plasma	plasma	O	O	O	O
are	are	O	O	O	O
frequently	frequently	O	O	O	O
used	used	O	O	O	O
in	in	O	O	O	O
neurosurgery	neurosurgery	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
order	order	O	O	O	O
to	to	O	O	O	O
increase	increase	O	O	O	O
clot	clot	O	O	O	O
stability	stability	O	O	O	O
,	,	O	O	O	O
FS	fs	O	O	O	O
typically	typically	O	O	O	O
contain	contain	O	O	O	O
aprotinin	aprotinin	O	O	O	O
,	,	O	O	O	O
a	a	O	O	O	O
natural	natural	O	O	O	O
fibrinolysis	fibrinolysis	O	O	O	O
inhibitor	inhibitor	O	O	O	O
.	.	O	O	O	O

Recently	recently	O	O	O	O
,	,	O	O	O	O
synthetic	synthetic	O	O	O	O
fibrinolysis	fibrinolysis	O	O	O	O
inhibitors	inhibitors	O	O	O	O
such	such	O	O	O	O
as	as	O	O	O	O
tranexamic	tranexamic	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
tAMCA	tamca	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
have	have	O	O	O	O
been	been	O	O	O	O
considered	considered	O	O	O	O
as	as	O	O	O	O
substitutes	substitutes	O	O	O	O
for	for	O	O	O	O
aprotinin	aprotinin	O	O	O	O
.	.	O	O	O	O

However	however	O	O	O	O
,	,	O	O	O	O
tAMCA	tamca	CHEMICALS	O	OTHERS	I
has	has	O	O	O	O
been	been	O	O	O	O
shown	shown	O	O	O	O
to	to	O	O	O	O
cause	cause	O	O	O	O
epileptic	epileptic	O	DISEASE	OTHERS	I
seizures	seizures	O	DISEASE	OTHERS	I
.	.	O	O	O	O

We	we	O	O	O	O
wanted	wanted	O	O	O	O
to	to	O	O	O	O
study	study	O	O	O	O
whether	whether	O	O	O	O
tAMCA	tamca	CHEMICALS	O	OTHERS	I
retains	retains	O	O	O	O
its	its	O	O	O	O
convulsive	convulsive	O	DISEASE	OTHERS	I
action	action	O	O	O	O
if	if	O	O	O	O
incorporated	incorporated	O	O	O	O
into	into	O	O	O	O
a	a	O	O	O	O
FS	fs	O	O	O	O
.	.	O	O	O	O

METHOD	method	O	O	O	O
:	:	O	O	O	O
FS	fs	O	O	O	O
containing	containing	O	O	O	O
aprotinin	aprotinin	O	O	O	O
or	or	O	O	O	O
different	different	O	O	O	O
concentrations	concentrations	O	O	O	O
of	of	O	O	O	O
tAMCA	tamca	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
0.5	0.5	O	O	O	O
-	-	O	O	O	O
47.5	47.5	O	O	O	O
mg/ml	mg/ml	O	O	O	O
)	)	O	O	O	O
were	were	O	O	O	O
applied	applied	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
pial	pial	O	O	O	O
surface	surface	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
cortex	cortex	O	O	O	O
of	of	O	O	O	O
anaesthetized	anaesthetized	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
response	response	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
animals	animals	O	O	O	O
was	was	O	O	O	O
evaluated	evaluated	O	O	O	O
using	using	O	O	O	O
electroencephalography	electroencephalography	O	O	O	O
and	and	O	O	O	O
by	by	O	O	O	O
monitoring	monitoring	O	O	O	O
the	the	O	O	O	O
clinical	clinical	O	O	O	O
behaviour	behaviour	O	O	O	O
during	during	O	O	O	O
and	and	O	O	O	O
after	after	O	O	O	O
recovery	recovery	O	O	O	O
from	from	O	O	O	O
anaesthesia	anaesthesia	O	O	O	O
.	.	O	O	O	O

FINDINGS	findings	O	O	O	O
:	:	O	O	O	O
FS	fs	O	O	O	O
containing	containing	O	O	O	O
tAMCA	tamca	CHEMICALS	O	OTHERS	I
caused	caused	O	O	O	O
paroxysmal	paroxysmal	O	O	O	O
brain	brain	O	O	O	O
activity	activity	O	O	O	O
which	which	O	O	O	O
was	was	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
distinct	distinct	O	O	O	O
convulsive	convulsive	O	DISEASE	OTHERS	I
behaviours	behaviours	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
degree	degree	O	O	O	O
of	of	O	O	O	O
these	these	O	O	O	O
seizures	seizures	O	DISEASE	OTHERS	I
increased	increased	O	O	O	O
with	with	O	O	O	O
increasing	increasing	O	O	O	O
concentration	concentration	O	O	O	O
of	of	O	O	O	O
tAMCA	tamca	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Thus	thus	O	O	O	O
,	,	O	O	O	O
FS	fs	O	O	O	O
containing	containing	O	O	O	O
47.5	47.5	O	O	O	O
mg/ml	mg/ml	O	O	O	O
tAMCA	tamca	CHEMICALS	O	OTHERS	I
evoked	evoked	O	O	O	O
generalized	generalized	O	O	OTHERS	I
seizures	seizures	O	DISEASE	OTHERS	I
in	in	O	O	O	O
all	all	O	O	O	O
tested	tested	O	O	O	O
rats	rats	O	O	O	O
(	(	O	O	O	O
n=6	n=6	O	O	O	O
)	)	O	O	O	O
while	while	O	O	O	O
the	the	O	O	O	O
lowest	lowest	O	O	O	O
concentration	concentration	O	O	O	O
of	of	O	O	O	O
tAMCA	tamca	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
0.5	0.5	O	O	O	O
mg/ml	mg/ml	O	O	O	O
)	)	O	O	O	O
only	only	O	O	O	O
evoked	evoked	O	O	O	O
brief	brief	O	O	O	O
episodes	episodes	O	O	O	O
of	of	O	O	O	O
jerk-correlated	jerk-correlated	O	O	O	O
convulsive	convulsive	O	DISEASE	OTHERS	I
potentials	potentials	O	O	O	O
in	in	O	O	O	O
1	1	O	O	O	O
of	of	O	O	O	O
6	6	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
contrast	contrast	O	O	OTHERS	I
,	,	O	O	O	O
FS	fs	O	O	O	O
containing	containing	O	O	O	O
aprotinin	aprotinin	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
evoke	evoke	O	O	O	O
any	any	O	O	O	O
paroxysmal	paroxysmal	O	O	O	O
activity	activity	O	O	O	O
.	.	O	O	O	O

INTERPRETATION	interpretation	O	O	O	O
:	:	O	O	O	O
Tranexamic	tranexamic	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
retains	retains	O	O	O	O
its	its	O	O	O	O
convulsive	convulsive	O	DISEASE	OTHERS	I
action	action	O	O	O	O
within	within	O	O	O	O
FS	fs	O	O	O	O
.	.	O	O	O	O

Thus	thus	O	O	O	O
,	,	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
FS	fs	O	O	O	O
containing	containing	O	O	O	O
tAMCA	tamca	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
surgery	surgery	O	O	O	O
within	within	O	O	O	O
or	or	O	O	O	O
close	close	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
CNS	cns	O	O	O	O
may	may	O	O	O	O
pose	pose	O	O	O	O
a	a	O	O	O	O
substantial	substantial	O	O	O	O
risk	risk	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
patient	patient	O	O	O	O
.	.	O	O	O	O

